Ye Xin, Fan Weijun, Wang Hui, Wang Junjie, Wang Zhongmin, Gu Shanzhi, Feng Weijian, Zhuang Yiping, Liu Baodong, Li Xiaoguang, Li Yuliang, Li Chengli, Xiao Yueyong, Yang Po, Yang Xia, Yang Wuwei, Chen Junhui, Zhang Rong, Lin Zhengyu, Meng Zhiqiang, Hu Kaiwen, Liu Chen, Peng Zhongmin, Han Yue, Jin Yong, Lei Guangyan, Zhai Bo, Huang Guanghui
Department of Oncology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China.
Imaging and Interventional Center, Sun Yat-Sen University Cancer Center, Guangzhou, China.
J Cancer Res Ther. 2018;14(4):730-744. doi: 10.4103/jcrt.JCRT_221_18.
Although surgical resection with curative intent is the main therapy for both primary and metastatic lung tumors, about 80% of lung cancers cannot be removed by surgery. Because most patients with unresectable lung cancer only receive limited benefits from traditional radiotherapy and chemotherapy, many novel local treatment modalities have emerged including local ablation therapy. The Minimally Invasive Treatment of Lung Cancer Branch, Professional Committee of Minimally Invasive Treatment of Cancer of the Chinese Anti-Cancer Association and Committee on Tumor Ablations, Chinese College of Interventionalists have organized multidisciplinary experts to develop guidelines for this treatment modality. These guidelines aim at standardizing thermal ablation procedures, describing the indications for candidates, assessing outcomes, and preventing postablation complications.
尽管以治愈为目的的手术切除是原发性和转移性肺肿瘤的主要治疗方法,但约80%的肺癌无法通过手术切除。由于大多数无法切除的肺癌患者从传统放疗和化疗中仅获得有限的益处,因此出现了许多新型局部治疗方式,包括局部消融治疗。中国抗癌协会微创治疗专业委员会肺癌微创治疗分会和中国介入医师学会肿瘤消融治疗委员会组织了多学科专家制定这种治疗方式的指南。这些指南旨在规范热消融程序,描述候选者的适应症,评估疗效,并预防消融后并发症。